Literature DB >> 20555083

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P C W Hogendoorn1, N Athanasou, S Bielack, E De Alava, A P Dei Tos, S Ferrari, H Gelderblom, R Grimer, K Sundby Hall, B Hassan, P C W Hogendoorn1, H Jurgens, M Paulussen, L Rozeman, A H M Taminiau, J Whelan, D Vanel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20555083     DOI： 10.1093/annonc/mdq223

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  65 in total

Review 1.  Imaging features of primary and secondary malignant tumours of the sacrum.

Authors:  E Thornton; K M Krajewski; K N O'Regan; A A Giardino; J P Jagannathan; N Ramaiya
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  The Establishment and Utility of a Free Online Database of Primary Bone Tumors.

Authors:  Hairong Xu; Robert P Seifert; Xiaohui Niu; Yuan Li; Marilyn M Bui
Journal:  Pathol Oncol Res       Date:  2015-09-16       Impact factor: 3.201

3.  Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.

Authors:  J S Whelan; R C Jinks; A McTiernan; M R Sydes; J M Hook; L Trani; B Uscinska; V Bramwell; I J Lewis; M A Nooij; M van Glabbeke; R J Grimer; P C W Hogendoorn; A H M Taminiau; H Gelderblom
Journal:  Ann Oncol       Date:  2011-10-19       Impact factor: 32.976

4.  Osteoporosis in children and young adults: a late effect after chemotherapy for bone sarcoma.

Authors:  Ulrike Michaela Pirker-Frühauf; Jörg Friesenbichler; Ernst-Christian Urban; Barbara Obermayer-Pietsch; Andreas Leithner
Journal:  Clin Orthop Relat Res       Date:  2012-07-18       Impact factor: 4.176

5.  Invariant NKT cells increase drug-induced osteosarcoma cell death.

Authors:  S Fallarini; T Paoletti; N Orsi Battaglini; G Lombardi
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

6.  Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trials.

Authors:  Sasan Partovi; Andres A Kohan; Lisa Zipp; Peter Faulhaber; Christos Kosmas; Pablo R Ros; Mark R Robbin
Journal:  Int J Clin Exp Med       Date:  2014-03-15

7.  Polycaprolactone scaffold as targeted drug delivery system and cell attachment scaffold for postsurgical care of limb salvage.

Authors:  Bin Sheng Wong; Swee-Hin Teoh; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

8.  Role of β-isomerized C-terminal telopeptides (β-CTx) and total procollagen type 1 amino-terminal propeptide (tP1NP) as osteosarcoma biomarkers.

Authors:  Tu Hu; Qingcheng Yang; Jing Xu; Zhichang Zhang; Nengbin He; Yuzhen Du
Journal:  Int J Clin Exp Med       Date:  2015-01-15

9.  Clinical significance of traditional clinical parameters and inflammatory biomarkers for the prognosis of patients with spinal chondrosarcoma: a retrospective study of 150 patients in a single center.

Authors:  Kehan Xu; Bo Li; Quan Huang; Dongjie Jiang; Haitao Sun; Nanzhe Zhong; Wei Wan; Haifeng Wei; Jianru Xiao
Journal:  Eur Spine J       Date:  2019-05-04       Impact factor: 3.134

10.  Circulating miR-215-5p and miR-642a-5p as potential biomarker for diagnosis of osteosarcoma in Mexican population.

Authors:  Lucero Monterde-Cruz; Eric G Ramírez-Salazar; Genaro Rico-Martínez; Luis M Linares-González; Roberto Guzmán-González; Ernesto Delgado-Cedillo; Eréndira Estrada-Villaseñor; Margarita Valdés-Flores; Rafael Velázquez-Cruz; Alberto Hidalgo-Bravo
Journal:  Hum Cell       Date:  2018-06-15       Impact factor: 4.174
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.